secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2025-08-20T23:59:59+00:00
Accession:  0000950170-25-110484
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos regains Nasdaq compliance after reporting $3.66M equity in Q2 2025
--------------------------------------------------------------------------

- Nasdaq notified Alaunos of compliance on August 19, 2025, following prior stockholders' equity deficiency.
- Company had reported $2.06M equity in 2024 10-K, below $2.5M minimum for continued listing.
- Q2 2025 10-Q showed $3.66M equity, meeting Nasdaq's requirement; compliance plan submitted earlier.
- Matter closed; no immediate delisting risk.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025110484/0000950170-25-110484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025110484/tcrt-20250819.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-110484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer